Maria Słomka

Maria Słomka

Auto-generated profile, based on publicly available information

Maria Słomka

Department of Gastroenterology with Endoscopy Unit, Medical University of Lublin, 8 Jaczewski Street, 20-954 Lublin, Poland

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2003 in Journal of Hepato-Biliary-Pancreatic Surgery
Verified
Journal Article
Closed access
PDF file
SSStanisLawa Szymonik-Lesiuk
StanisLawa Szymonik-Lesiuk
GCGraZyna Czechowska
GraZyna Czechowska
MSMarta Stryjecka-Zimmer
Marta Stryjecka-Zimmer
MSMaria Slomka
Maria Slomka
AMAgnieszka Maldro
Agnieszka Maldro
MWMarian Wielosz
Marian Wielosz

1 January 2012 in Medical Science Monitor
Verified
Journal Article
Open access
HCHalina Cichoz-Lach
Halina Cichoz-Lach
KCKrzysztof Celiński
Krzysztof Celiński
BPBeata Prozorow-Król
Beata Prozorow-Król
JSJarosław Swatek
Jarosław Swatek
MSMaria Słomka
Maria Słomka
TLTomasz Lach
Tomasz Lach
Non-alcoholic fatty liver disease (NAFLD) refers to a very wide clinical spectrum. Advanced fibrosis that accompanies disease leads to the development of cirrhosis and hepatocellular carcinoma. Thus, identification of patients with advanced fibrosis is essential. The aim of the present study was to compare the usefulness of NAFLD fibrosis and BARD scores in predicting fibrosis in NAFLD and to determine the risk factors of advanced fibrosis. The study included 126 patients with NAFLD. Fibrosis in liver biopsy was scored on a 5-point scale. The BARD and the NAFLD fibrosis scores were compared with the biopsy findings. Liver biopsy revealed 27 patients with advanced and 99 with mild/moderate fibrosis. Advanced fibrosis was statistically significantly more common in older patients with obesity, AST/ALT ratio ≥0.8, diabetes mellitus, and thrombocytes ≤200×103/L. Positive predictive value, negative predictive value and AUROC curve for BARD score, and NAFLD fibrosis score were 68.57%, 96.70%, 0.865 and 70.59%, 98.11%, 0.919, respectively. Both scores are capable of ruling out advanced fibrosis and markedly reducing the need for liver biopsies in patients with NAFLD. Obesity, diabetes mellitus, thrombocytes ≤200×103/L, advanced age and AST/ALT ratio ≥0.8 are the risk factors of advanced fibrosis.

8 April 2010 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
PKP. C. Konturek
P. C. Konturek
SKS. J. Konturek
S. J. Konturek
KCK. Celinski
K. Celinski
MSM. Slomka
M. Slomka
HCH. Cichoz‐Lach
H. Cichoz‐Lach
RRR. J. Reiter
R. J. Reiter

9 April 2009 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
KCK. Celinski
K. Celinski
PKP.C. Konturek
P.C. Konturek
MSM. Slomka
M. Slomka
HCH. Cichoz‐Lach
H. Cichoz‐Lach
MGM. Gonciarz
M. Gonciarz
SKS.J. Konturek
S.J. Konturek

1 March 2011 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
KCKrzysztof Celinski
Krzysztof Celinski
SKStanislaw J. Konturek
Stanislaw J. Konturek
PKPiotr C. Konturek
Piotr C. Konturek
TBThomas Brzozowski
Thomas Brzozowski
HCHalina Cichoz-Lach
Halina Cichoz-Lach
RRRussel J. Reiter
Russel J. Reiter

1 January 2012 in Polish Archives of Internal Medicine
Verified
Journal Article
Closed access
HCHalina Cichoz-Lach
Halina Cichoz-Lach
Beata Kasztelan-SzczerbinskaBeata Kasztelan-Szczerbinska
Beata Kasztelan-Szczerbinska
MSMaria Słomka
Maria Słomka
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. They originate from the myenteric ganglion cells, termed the interstitial Cajal cells. The majority, i.e. 95% of GIST, show expression of the membrane receptor protein CD117 with a tyrosine kinase activity c-kit. Gastrointestinal stromal tumors constitute less than 1% of all digestive tract tumors. They may be benign or malignant (30%), and occur in every part of the gastrointestinal tract, however the stomach is the most common localization. They develop with the same prevalence in men and in women, usually above the age of 50 years. The peak incidence is observed between the fifth and the sixth decade of life. Symptoms are not typical and depend on the localization and the tumor size. About 10-30% of GIST are completely asymptomatic, and are discovered accidentally during the endoscopy or X-rays evaluation as well as during surgical interventions performed for various reasons. The malignant tumors metastasize most commonly to the liver and peritoneum. The metastases are rarely found in the lungs, pleura and bones. The detection of GIST is based on imaging, endoscopy, histological and immunohistochemical examinations. A useful and promising diagnostic procedure is positron emission tomography. The final diagnosis is mostly based on the pathologic findings of the removed tumor. The prognosis of GIST depends on its size, mitotic activity in 50 high power fields and mucosal infiltration. Radical surgery is the best treatment of GIST.